Literature DB >> 24416572

Global radiation oncology waybill.

Victor Muñoz-Garzón1, Angeles Rovirosa2, Alfredo Ramos3.   

Abstract

BACKGROUND/AIM: Radiation oncology covers many different fields of knowledge and skills. Indeed, this medical specialty links physics, biology, research, and formation as well as surgical and clinical procedures and even rehabilitation and aesthetics. The current socio-economic situation and professional competences affect the development and future or this specialty. The aim of this article was to analyze and highlight the underlying pillars and foundations of radiation oncology, indicating the steps implicated in the future developments or competences of each.
METHODS: This study has collected data from the literature and includes highlights from discussions carried out during the XVII Congress of the Spanish Society of Radiation Oncology (SEOR) held in Vigo in June, 2013. Most of the aspects and domains of radiation oncology were analyzed, achieving recommendations for the many skills and knowledge related to physics, biology, research, and formation as well as surgical and clinical procedures and even supportive care and management.
RESULTS: Considering the data from the literature and the discussions of the XVII SEOR Meeting, the "waybill" for the forthcoming years has been described in this article including all the aspects related to the needs of radiation oncology.
CONCLUSIONS: Professional competences affect the development and future of this specialty. All the types of radio-modulation are competences of radiation oncologists. On the other hand, the pillars of Radiation Oncology are based on experience and research in every area of Radiation Oncology.

Keywords:  Radiation oncology; Radiation oncology future; Radiomodulation; Radiotherapy; Strategy; Waybill

Year:  2013        PMID: 24416572      PMCID: PMC3863245          DOI: 10.1016/j.rpor.2013.10.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  44 in total

1.  American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles.

Authors:  Akila N Viswanathan; Bruce Thomadsen
Journal:  Brachytherapy       Date:  2012 Jan-Feb       Impact factor: 2.362

Review 2.  The clinical application of intensity-modulated radiation therapy.

Authors:  Randall K Ten Haken; Theodore S Lawrence
Journal:  Semin Radiat Oncol       Date:  2006-10       Impact factor: 5.934

3.  Optimization by simulated annealing of three-dimensional conformal treatment planning for radiation fields defined by a multileaf collimator.

Authors:  S Webb
Journal:  Phys Med Biol       Date:  1991-09       Impact factor: 3.609

4.  Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines.

Authors:  Ece Algur; Roger M Macklis; Urs O Häfeli
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-02-01       Impact factor: 7.038

5.  Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx.

Authors:  S A Leibel; G J Kutcher; L B Harrison; D E Fass; C M Burman; M A Hunt; R Mohan; L J Brewster; C C Ling; Z Y Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-04       Impact factor: 7.038

6.  Metastatic breast cancer: we do need primary cost data.

Authors:  J Bonastre; P Jan; Y Barthe; S Koscielny
Journal:  Breast       Date:  2012-04-19       Impact factor: 4.380

Review 7.  Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.

Authors:  J Green; J Kirwan; J Tierney; C Vale; P Symonds; L Fresco; C Williams; M Collingwood
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

Review 8.  American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy.

Authors:  Juanita M Crook; Christine Haie-Meder; D Jeffrey Demanes; Jean-Jacques Mazeron; Alvaro A Martinez; Mark J Rivard
Journal:  Brachytherapy       Date:  2013-03-01       Impact factor: 2.362

9.  Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.

Authors:  Amye J Tevaarwerk; Robert J Gray; Bryan P Schneider; Mary Lou Smith; Lynne I Wagner; John H Fetting; Nancy Davidson; Lori J Goldstein; Kathy D Miller; Joseph A Sparano
Journal:  Cancer       Date:  2012-10-12       Impact factor: 6.860

Review 10.  Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications.

Authors:  Alexander Chi; Zhongxing Liao; Nam P Nguyen; Jiahong Xu; Baldassarre Stea; Ritsuko Komaki
Journal:  Radiother Oncol       Date:  2010-01-13       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.